The Medical Cannabis Council, launched in Melbourne on Thursday and will be the unifying voice for the industry to engage with governments on all matters concerning medical cannabis in Australia.
A new industry body has been formed to position Australia as a leader in the production of medical cannabis.
Medical experts who have long advocated for the regulated access to medical cannabis products are among the board members, including Carol Ireland, the CEO of Epilepsy Action Australia, and Professor Mark Cook, Head of Neurology at Melbourne’s St Vincent’s Hospital.
To date, fewer than 150 patients in Australia have access to medical cannabis, while the industry is still navigating the regulations around cultivation licensing. Supporting the medical cannabis industry in Australia, will ultimately ensure patients have greater access to medical cannabis in the future.
Read the full article on four20.com.au